Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players

Feb 21, 2020• Articles, Business Consultant, Pharma Consultant

Wet Age-related macular degeneration treatment market

Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade

Feb 17, 2020• Articles, Business Consultant, Pharma Consultant

With no effective cure in Wet Age-related macular degeneration (Wet AMD) treatment market, the need of new therapies that can not only slow...

Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D

Feb 14, 2020• Articles, Business Consultant, Pharma Consultant

Nearly 11 million Americans are living with one or other type of Age-Related Macular degeneration (AMD), estimates BrightFocus foundation....

The epidemic now has a name: COVID-19

Feb 12, 2020• Articles, Business Consultant, Pharma Consultant

Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReForm Biologics, MilliporeSigma

Feb 11, 2020• Articles, Business Consultant, Pharma Consultant

FDA has accepted Biological License Application submitted by Kite for its CAR-T cell therapy- KTE-X19, for relapsed or refractory mantle...

Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline

Feb 10, 2020• Articles, Business Consultant, Pharma Consultant

Slowly or rapidly growing bacteria- Nontuberculous mycobacteria (NTM), might appear innocuous, however, NTM infections have a notably...

How Artificial Intelligence is adding value to the Healthcare sector

Feb 7, 2020• Articles, Business Consultant, Pharma Consultant

Nontuberculous Mycobacteria Infection Market: Current status of NTM infection drug discovery and development

Feb 5, 2020• Articles

Nontuberculous mycobacteria (NTM) are members of the Mycobacterium genus other than Mycobacterium tuberculosis complex and Mycobacterium...

Lack of effective therapy: A major Nontuberculous Mycobacteria Infection Market Driver

Feb 3, 2020• Articles, Business Consultant, Pharma Consultant

Nontuberculous Mycobacteria (NTM) is a ubiquitous, aerobic, non-motile, acid-fast bacteria, which, when inhaled, may cause severe lung...

Wuhan Coronavirus: A global emergency

Jan 31, 2020• Articles, Business Consultant, Pharma Consultant

Articles

Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players

The epidemic now has a name: COVID-19

Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReForm Biologics, MilliporeSigma

Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline

How Artificial Intelligence is adding value to the Healthcare sector

Nontuberculous Mycobacteria Infection Market: Current status of NTM infection drug discovery and development

Lack of effective therapy: A major Nontuberculous Mycobacteria Infection Market Driver

Wuhan Coronavirus: A global emergency

Popular Posts

Recent Posts

Whitepaper/Newsletter

Categories

Trending Posts

Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players

Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prime Therapeutics’ pancreatic cancer a bust

Cardiovascular Disease: A major cause of health loss and a global burden

Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?

Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade

Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D

J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million for CD47 drug

The epidemic now has a name: COVID-19

Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReForm Biologics, MilliporeSigma

Bridging the gap: Nontuberculous mycobacterium Infections Drug Pipeline

Sections